Compounds > adenosine
Page last updated: 2024-08-24

adenosine and Cancer of the Thyroid

adenosine has been researched along with Cancer of the Thyroid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's1 (10.00)24.3611
2020's5 (50.00)2.80

Authors

AuthorsStudies
Ji, C; Lin, S; Long, M; Luo, D; Peng, X; Tan, L; Yu, W; Zhang, C; Zhu, Y1
Le, Y; Lu, D; Xue, M1
Fu, XH; He, Q; Ji, FH; Li, GQ; Qiu, XG1
Ji, FH; Lowe, S; Qiu, XG; Sun, C; Yang, Z1
Chu, J; He, F; He, J; Jia, J; Sheng, J; Wan, J; Wang, C; Yin, H; Yin, J; Zhou, M1
Cui, B; Guan, H; Hou, P; Ji, M; Shi, B; Yang, Q1
Forte, G; Morello, S; Petrella, A; Pinto, A; Popolo, A; Porta, A; Sorrentino, R1
Chiappetta, G; Festa, M; Monaco, M; Morello, S; Parente, L; Petrella, A; Pinto, A; Popolo, A; Vuttariello, E1
Guan, H; Hou, P; Ji, M; Liu, Z; Shan, Z; Teng, W; Wang, C; Xing, M1
Hescheler, J; Höflich, M; Raue, F; Scherübl, H; Zink, A1

Reviews

1 review(s) available for adenosine and Cancer of the Thyroid

ArticleYear
Purinergic signaling in thyroid disease.
    Purinergic signalling, 2023, Volume: 19, Issue:1

    Topics: Adenosine; Humans; Hyperthyroidism; Hypothyroidism; Nucleotides; Thyroid Neoplasms

2023

Other Studies

9 other study(ies) available for adenosine and Cancer of the Thyroid

ArticleYear
METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    The Journal of clinical endocrinology and metabolism, 2022, 01-18, Volume: 107, Issue:2

    Topics: Adenosine; Adult; Aged; Animals; Cell Transformation, Neoplastic; Down-Regulation; Female; Follow-Up Studies; Gene Knockdown Techniques; Humans; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Male; Methyltransferases; Mice; MicroRNAs; Middle Aged; Protein Serine-Threonine Kinases; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Up-Regulation; Xenograft Model Antitumor Assays

2022
FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Amino Acid Transport System y+; Animals; Epigenesis, Genetic; Ferroptosis; Methylation; Mice; Thyroid Neoplasms

2022
Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:1

    Topics: Adenosine; Humans; Methylation; RNA; Thyroid Neoplasms; Tumor Microenvironment

2023
METTL3 restrains papillary thyroid cancer progression via m
    Molecular therapy : the journal of the American Society of Gene Therapy, 2021, 05-05, Volume: 29, Issue:5

    Topics: Adenosine; Animals; Disease Progression; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Male; Methyltransferases; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neutrophil Infiltration; Prognosis; Proto-Oncogene Proteins c-rel; Sequence Analysis, RNA; Thyroid Cancer, Papillary; Thyroid Neoplasms

2021
PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:6

    Topics: Adenosine; Animals; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mice; Mice, Nude; Mutant Proteins; Thyroid Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2014
Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Journal of cellular physiology, 2009, Volume: 221, Issue:2

    Topics: Adenosine; Adenosine A3 Receptor Antagonists; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-rel; Receptor, Adenosine A3; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Thyroid Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2009
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Cancer biology & therapy, 2008, Volume: 7, Issue:2

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Dose-Response Relationship, Drug; G1 Phase; Humans; Immunohistochemistry; Thyroid Neoplasms; Time Factors

2008
Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer.
    Cancer, 2008, Jul-15, Volume: 113, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adenosine; Carcinoma, Papillary; Cell Line, Tumor; DNA Methylation; DNA Mismatch Repair; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; MAP Kinase Signaling System; Mutation; MutL Protein Homolog 1; Nuclear Proteins; Proto-Oncogene Proteins B-raf; Thymidine; Thyroid Neoplasms

2008
Adenosine A1-receptors inhibit cAMP and Ca2+ mediated calcitonin secretion in C-cells.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1995, Volume: 27, Issue:9

    Topics: Adenosine; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Calcitonin; Calcium; Calcium Channels; Carcinoma, Medullary; Cyclic AMP; Cytosol; Electrophysiology; Glucagon; Patch-Clamp Techniques; Pertussis Toxin; Phenylisopropyladenosine; Rats; Receptors, Purinergic P1; Thyroid Neoplasms; Tumor Cells, Cultured; Virulence Factors, Bordetella

1995